Cargando...

Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines

This study investigated the effects on the tumor microenvironment of combining antiangiogenic tyrosine kinase inhibitors (TKI) with therapeutic vaccines, and in particular, how vascular changes affect tumor-infiltrating immune cells. We conducted studies using a TKI (sunitinib or sorafenib) in combi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Immunol Res
Autores principales: Farsaci, Benedetto, Donahue, Renee N., Coplin, Michael A., Grenga, Italia, Lepone, Lauren M., Molinolo, Alfredo A., Hodge, James W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221465/
https://ncbi.nlm.nih.gov/pubmed/25092771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0076
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!